REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcript February 27, 2024
REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.43 EPS, expectations were $-1.27. REGENXBIO Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good day, and thank you for standing by. Welcome to REGENXBIO’s Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode....
